Brody's Human Pharmacology

1. Chapter 1: Introduction - p. iii 2. Chapter 2: Introduction - p. iii 3. Chapter 3: Pharmacodynamics: Receptors and Concentration-Response Relationships - p. iii 4. Chapter 4: Pharmacokinetics - p. iii 5. Chapter 5: Pharmacogenetics - p. iii 6. Chapter 6: Drug Discovery, Development, and Regulation - p. iii 7. Section 2: Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses - p. iii 8. Chapter 7: Introduction - p. iii 9. Chapter 8: Introduction to the Autonomic Nervous System - p. iii 10. Cholinergic Drugs - p. iii 11. Chapter 9: Muscarinic Agonists, Cholinesterase Inhibitors, and Their Clinical Uses - p. iii 12. Chapter 10: Muscarinic Antagonists and Their Clinical Uses - p. iii 13. Chapter 11: Nicotinic Agonists and Their Clinical Uses - p. iii 14. Chapter 12: Neuromuscular Blocking Drugs and Nicotinic Antagonists - p. iii 15. Adrenergic Drugs - p. iii 16. Chapter 13: Adrenergic Agonists and Their Clinical Uses - p. iii 17. Chapter 14: Adrenergic Antagonists and Their Clinical Uses - p. iii 18. Section 3: Drug Treatment for Disorders Affecting the Central Nervous System - p. iii 19. Chapter 15: Introduction - p. iii 20. Chapter 16: The Central Nervous System - p. iii 21. Chapter 17: Drug Therapy for Alzheimer Disease and Other Cognitive Disorders/Dementias - p. iii 22. Chapter 18: Pharmacotherapy of Basal Ganglia Disorders: Parkinson Disease and Huntington Disease - p. iii 23. Chapter 19: Drug Therapy for Psychoses and Bipolar Disorder - p. iii 24. Chapter 20: Drug Therapy for Depression and Anxiety - p. iii 25. Chapter 21: Drug Therapy for the Management of Attention Deficit-Hyperactivity Disorder - p. iii 26. Chapter 22: Drug Therapy for Insomnia and the Hypersomnias - p. iii 27. Chapter 23: Drug Therapy for Managing Obesity and Eating Disorders - p. iii 28. Chapter 24: Treatment of Seizure Disorders - p. iii 29. Chapter 25: Drug Therapy for Spasticity Disorders - p. iii 30. Chapter 26: Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder - p. iii 31. Chapter 27: Illicit Psychoactive Compounds and Substance Use Disorder - p. iii 32. Section 4: Drug Therapy for Pain Management - p. iii 33. Chapter 28: Introduction - p. iii 34. Chapter 29: Introduction - p. iii 35. Chapter 30: General Anesthetics - p. iii 36. Chapter 31: Local Anesthetics - p. iii 37. Chapter 32: Opioid Analgesics - p. iii 38. Chapter 33: Nonsteroidal Antiinflammatory Agents and Acetaminophen - p. iii 39. Chapter 34: Cannabinoids as Analgesics - p. iii 40. Section 5: Treatment of Inflammatory, Allergic and Immunological Disorders - p. iii 41. Chapter 35: Introduction - p. iii 42. Chapter 36: Drug Therapy for Migraine Headache - p. iii 43. Chapter 37: Drug Therapy for Gout and Hyperuricemia - p. iii 44. Chapter 38: Drug Treatment for Allergic Reactions - p. iii 45. Chapter 39: Immunosuppressants for Autoimmune Disorders and Organ Transplantation - p. iii 46. Chapter 40: Drug Therapy for Rheumatoid Arthritis - p. iii 47. Section 6: Drug Treatment for Cardiovascular Diseases - p. iii 48. Chapter 41: Introduction - p. iii 49. Chapter 42: Introduction to the Regulation of Cardiovascular Function - p. iii 50. Chapter 43: Overview of Hypertension Management and Drugs That Decrease Sympathetic Tone - p. iii 51. Chapter 44: Diuretics and Drugs That Affect Volume and Electrolyte Content - p. iii 52. Chapter 45: Drugs Affecting the Renin-Angiotensin-Aldosterone System - p. iii 53. Chapter 46: Calcium Channel Blockers - p. iii 54. Chapter 47: Vasodilators for Hypertensive Crises, Pulmonary Hypertension, and Erectile Dysfunction - p. iii 55. Chapter 48: Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease - p. iii 56. Chapter 49: Drug Therapy for Myocardial Ischemia and Angina Pectoris - p. g0010 57. Chapter 50: Treatment of Heart Failure - p. g0010 58. Chapter 51: Antiarrhythmic Drugs - p. g0010 59. Chapter 52: Anticoagulant, Fibrinolytic, and Antiplatelet Agents - p. g0010 60. Chapter 53: Drug Therapy for Hemophilia and the Deficiency Anemias - p. g0010 61. Section 7: Endocrine Pharmacology - p. g0010 62. Chapter 54: Introduction - p. g0010 63. Chapter 55: Introduction to Endocrine Pharmacology - p. g0010 64. Chapter 56: Treatment of Hypothalamic and Pituitary Disorders - p. g0010 65. Chapter 57: Treatment of Adrenocorticosteroid Disorders - p. g0010 66. Chapter 58: Female Hormone Regulation - p. g0010 67. Chapter 59: Androgens, Antiandrogens, and Their Clinical Uses - p. g0010 68. Chapter 60: Drug Therapy for the Management of Diabetes - p. g0010 69. Chapter 61: Drug Therapy for the Management of Thyroid Disorders - p. g0010 70. Chapter 62: Calcium Regulating Hormones and Other Agents Affecting Bone - p. g0010 71. Section 8: Chemotherapy - p. g0010 72. Chapter 63: Introduction - p. g0010 73. Infectious Diseases - p. g0010 74. Chapter 64: Principles of Antimicrobial Use - p. g0010 75. Chapter 65: Drugs Targeting Bacterial Cell Walls and Membranes - p. g0010 76. Chapter 66: Drugs Targeting Bacterial Protein Synthesis - p. g0010 77. Chapter 67: Drugs Targeting Bacterial DNA - p. g0010 78. Chapter 68: Antimycobacterial Agents - p. g0010 79. Chapter 69: Drugs Targeting Resistant Organisms - p. g0010 80. Parasitic Diseases - p. g0010 81. Chapter 70: Antifungal Agents - p. g0010 82. Chapter 71: Antimalarial and Other Antiprotozoal Agents - p. g0010 83. Chapter 72: Anthelmintics and Ectoparasiticides - p. g0010 84. Viruses - p. g0010 85. Chapter 73: Antiviral Agents - p. g0010 86. Chapter 74: Antiretroviral Drugs for HIV - p. g0010 87. Cancer - p. g0010 88. Chapter 75: Principles of Antineoplastic Drug Use - p. g0010 89. Chapter 76: Cytotoxic Agents - p. g0010 90. Chapter 77: Targeted Anticancer Agents - p. g0010 91. Section 9: Special Considerations - p. g0010 92. Chapter 78: Introduction - p. g0010 93. Chapter 79: Therapeutic Use of Hematopoietic Growth Factors - p. g0010 94. Chapter 80: Gastrointestinal Disorders and Their Treatment - p. g0010 95. Chapter 81: Pharmacological Treatment of Asthma and COPD - p. g0010 96. Chapter 82: The Role of Nutraceuticals and Natural Products - p. g0010 97. Chapter 83: Essentials of Toxicology - p. g0010 98. Chapter 84: Therapeutic Considerations for Pregnant, Pediatric, Geriatric, and Obese Individuals - p. g0010 99. Appendix - p. g0010 100. Index - p. g0010